Order Article Reprints

Nakagami H, Hayashi H, Sun J, Yanagida Y, Otera T, Nakagami F, Hamaguchi S, Yoshida H, Okuno H, Yoshida S, et al. Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults. Vaccines. 2022; 10(9):1427. https://doi.org/10.3390/vaccines10091427

Nakagami, Hironori, Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Futoshi Nakagami, Shigeto Hamaguchi, Hisao Yoshida, Hideo Okuno, Shota Yoshida, and et al. 2022. "Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults" Vaccines 10, no. 9: 1427. https://doi.org/10.3390/vaccines10091427

Nakagami, H., Hayashi, H., Sun, J., Yanagida, Y., Otera, T., Nakagami, F., Hamaguchi, S., Yoshida, H., Okuno, H., Yoshida, S., Nakamaru, R., Yokoyama, S., Fujimoto, T., Hongyo, K., Akeda, Y., Morishita, R., Tomono, K., & Rakugi, H. (2022). Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults. Vaccines, 10(9), 1427. https://doi.org/10.3390/vaccines10091427